Evidence map›Paper›PMID 41440223›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

Magnesium Depletion Score as a Prognostic Indicator in Endometrial Cancer: A Retrospective Cohort Study.

Aykut Turhan, Neslihan Özyurt, Müge Sönmez

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Aykut TurhanDepartment of Medical Oncology, Ordu University Training and Research Hospital, Altınordu 52200, Ordu, Turkey.ORCID 0000-0002-2535-9816
Neslihan ÖzyurtDepartment of Medical Oncology, Ordu University Training and Research Hospital, Altınordu 52200, Ordu, Turkey.ORCID 0000-0002-1404-8983
Müge SönmezDepartment of Medical Oncology, Ordu State Hospital, Altınordu 52200, Ordu, Turkey.ORCID 0000-0003-0839-8191

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnesium is essential for cellular metabolism, and its deficiency has been associated with adverse outcomes in various cancers. The MDS, which considers factors such as diuretic and proton pump inhibitor use, alcohol consumption, and kidney function, is a practical indicator of Mg deficiency. This retrospective cohort study assessed 200 patients with EC treated between 2010 and 2024 to explore the prognostic value of MDS. Patients were divided into low (0-1), intermediate (2), and high (≥3) MDS risk categories. Higher MDSs were significantly associated with older age, comorbid conditions, hypertension, diabetes, and reduced serum magnesium and vitamin D levels (all

Indexed as

Endometrial NeoplasmsMagnesiumMagnesium DeficiencyAdultAgedAged, 80 and overFemaleHumansMiddle AgedPrognosisRetrospective StudiesMagnesiumendometrial cancermagnesium deficiencymagnesium depletion scoreprognostic factorssurvival analysis

Identifiers

PMID41440223
PMCPMC12731353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.